Mx2 expression is associated with reduced susceptibility to HIV infection in highly exposed HIV seronegative kenyan sex workers

AIDS

Volumn 29, Issue 1, 2015, Pages 35-41

  Stein, Derek R ^a,d   Shaw, Souradet Y ^b   McKinnon, Lyle R ^c   Abou, Max ^d   McCorrister, Stuart J ^e   Westmacott, Garrett R ^e   Fowke, Keith R ^a   Plummer, Francis A ^a   Ball, T Blake ^a,d  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Department of Community Health Sciences ^*  (Canada)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d National HIV and Retrovirology Laboratories JC Wilt Infectious Disease Research Centre   (Canada)

^e PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Depo Provera; DMPA; Highly exposed HIV seronegative; Highly exposed HIV seronegative; HIV; Mx2

Indexed keywords

BIOLOGICAL FACTOR; MEDROXYPROGESTERONE ACETATE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MX1; TRANSCRIPTION FACTOR MX2; UNCLASSIFIED DRUG; MX1 PROTEIN, HUMAN; MX2 PROTEIN, HUMAN; MYXOVIRUS RESISTANCE PROTEIN;

ADULT; AGE; ARTICLE; CELL ISOLATION; CELL LYSATE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RISK POPULATION; HORMONE RESPONSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENT CELL; INFECTION SENSITIVITY; KENYAN; MAJOR CLINICAL STUDY; MENOPAUSE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSTITUTION; PROTEIN EXPRESSION; SEROLOGY; WHOLE CELL; DISEASE PREDISPOSITION; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; INNATE IMMUNITY; KENYA; MONONUCLEAR CELL; PROTEOMICS; SERODIAGNOSIS;

ADULT; DISEASE SUSCEPTIBILITY; FEMALE; HIV INFECTIONS; HIV SERONEGATIVITY; HIV-1; HUMANS; IMMUNITY, INNATE; KENYA; LEUKOCYTES, MONONUCLEAR; MEDROXYPROGESTERONE ACETATE; MYXOVIRUS RESISTANCE PROTEINS; PROTEOMICS; SEX WORKERS;

EID: 84928028356     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000490     Document Type: Article

References (19)

1. Fowke KR, Nagelkerke NJ, Kimani J, Simonsen JN, Anzala AO, Bwayo JJ, et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 1996; 348:1347-1351
2. Ball TB, Ji H, Kimani J, Mclaren P, Marlin C, Hill AVS, et al. Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers. AIDS 2007; 21:1091-1101
3. Card CM, Ball TB, Fowke KR. Immune Quiescence: a model of protection against HIV infection. Retrovirology 2013; 10:141
4. Burgener A, Rahman S, Ahmad R, Lajoie J, Ramdahin S, Mesa C, et al. Comprehensive proteomic study identifies serpin and cystatin antiproteases as novel correlates of HIV-1 resistance in the cervicovaginal mucosa of female sex workers. J Proteome Res 2011; 10:5139-5149
5. SteinDR, Burgener A,BallTB. Proteomics as a novelHIVimmune monitoring tool. Curr Opin HIV AIDS 2013; 8:140-146
6. Su RC, Sivro A, Kimani J, Jaoko W, Plummer FA, Ball TB. Epigenetic control of IRF1 responses in HIV-exposed seronegative versus HIV-susceptible individuals. Blood 2011; 117:2649-2657
7. Sandler NG, Bosinger SE, Estes JD, Zhu RTR, Tharp GK, Boritz E, et al. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 2014; 511:601-605
8. Kane M, Yadav SS, Bitzegeio J, Kutluay SB, Zang T, Wilson SJ, et al. MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 2013; 502:563-566
9. Goujon C, Moncorgé O, Bauby H, Doyle T, Ward CC, Schaller T, et al. Human MX2 is an interferon-induced postentry inhibitor of HIV-1 infection. Nature 2013; 502:559-562
10. Liu Z, Pan Q, Ding S, Qian J, Xu F, Zhou J, et al. The Interferon-Inducible MxB Protein Inhibits HIV-1 Infection. Cell Host Microbe 2013; 14:398-410
11. Haller O. Dynamins are forever: MxB inhibits HIV-1. Cell Host Microbe 2013; 14:371-373
12. Wis̈niewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Meth 2009; 6:359-362
13. Stein DR, Hu X, McCorrister SJ, Westmacott GR, Plummer FA, Ball TB, et al. High pH reversed-phase chromatography as a superior fractionation scheme compared to off-gel isoelectric focusing for complex proteome analysis. Proteomics 2013; 13:2956-2966
14. McCoy SI, Zheng W, Montgomery ET, Blanchard K, van der Straten A, De Bruyn G, et al. Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa. AIDS 2013; 27:1001-1009
15. Morrison CS, Chen P-L, Kwok C, Richardson BA, Chipato T, Mugerwa R, et al. Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS 2010; 24:1778-1781
16. Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 2012; 12:19-26
17. Hughes GC, Thomas S, Li C, Kaja M-K, Clark EA. Cutting edge: progesterone regulates IFN-alpha production by plasmacytoid dendritic cells. J Immunol 2008; 180:2029-2033
18. Tayel SS, Helmy AA, Ahmed R, Esmat G, Hamdi N, Abdelaziz AI. Progesterone suppresses interferon signaling by repressing TLR-7 and MxA expression in peripheral blood mononuclear cells of patients infected with hepatitis C virus. Arch Virol 2013; 158:1755-1764
19. Sironi M, Biasin M, Cagliani R, Gnudi F, Saulle I, Ibba S, et al. Evolutionary analysis identifies an MX2 haplotype associated with natural resistance to HIV-1 infection. Mol Biol Evol 2014; 31:2402-2414.